MICK | Translational Microbiome Platform

Summary
Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess and monitor it. Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming.
We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice. MICK automated platform analyses microbiome raw data in real-time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations.
MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining up to 75% cost reduction and faster TAT compared to existing solutions.
Results, demos, etc. Show all and search (2)
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190195702
Start date: 01-09-2022
End date: 31-08-2024
Total budget - Public funding: 3 080 973,75 Euro - 2 156 681,00 Euro
Cordis data

Original description

Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess and monitor it. Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming.
We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice. MICK automated platform analyses microbiome raw data in real-time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations.
MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining up to 75% cost reduction and faster TAT compared to existing solutions.

Status

SIGNED

Call topic

HORIZON-EIC-2021-ACCELERATOROPEN-01

Update Date

09-02-2023
Images
No images available.
Geographical location(s)